Elucid Bioimaging Inc. — Form D
Elucid Bioimaging Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-10. The offering totals $1.5M, of which $375K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-09-10
- Form: D
- Accession: 0001585931-13-000001
- Industry: Biotechnology
- Exemptions: 05, 46
- Total offering: $1.5M
- Amount sold: $375K
- Remaining: $1.1M
- Minimum investment: $100K
- Investors: 1
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-202620
Issuer
- Name: Elucid Bioimaging Inc.
- CIK: 0001585931
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 399 Boylston Street, BOSTON, MA, 02116
- Phone: 617-329-9487
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Andrew J Buckler | Executive Officer | Wenham, MA |
| Evan Melrose | Director | Boston, MA |
| Michael Lesh | Director | Boston, MA |
| Blake Richards | Director | Boston, MA |
| Blake Richards | Executive Officer | Boston, MA |
| Richard Kuntz | Director | Boston, MA |
| Rajesh Panda | Director | Boston, MA |
| Kelly Huang | Director | Boston, MA |
| Kelly Huang | Executive Officer | Boston, MA |
| Shamiram Feinglass | Director | Boston, MA |
| Scott Huennekens | Director | Boston, MA |
| Scott Huennekens | Executive Officer | Boston, MA |
| Robert Braun | Director | Boston, MA |
Other filings by this issuer (2)
More